Primitive Neuroectodermal Tumor — Trials

Primitive Neuroectodermal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

673 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 146
Recruiting: 80
Ph III recruiting: 8
Growth YoY: −33.3%
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (86)

clinicaltrialsPublishedShowing 301–350 of 673 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02998983	Racotumomab in Patients With High-risk Neuroblastoma	completed	Phase 2	39	Laboratorio Elea Phoenix S.A.INDUSTRY	1	Sep 11, 2023	clinicaltrials
NCT01728155	European Low and Intermediate Risk Neuroblastoma Protocol	completed	Phase 3	685	Instituto de Investigacion Sanitaria La FeOTHER	10	Sep 8, 2023	clinicaltrials
NCT02536183